Chemicals · Founded 1981 · www.mangalamorganics.com · BSE 514418 · NSE MANORG · ISIN INE370D01013
No Notes Added Yet
Business
Mangalam Organics Ltd. is an Indian chemical company primarily engaged in the manufacturing and selling of terpene chemistry products and specialty chemicals. Its core business revolves around derivatives of turpentine oil, such as pine chemicals. The company manufactures various products including Camphor (used in pharmaceuticals, religious ceremonies, and fragrances), Synthetic Resins (used in adhesives, coatings, printing inks), and By-products like Dipentene, Pinene, and Isobornyl Acetate, which find applications in flavors, fragrances, and industrial solvents. The company makes money by processing raw turpentine oil into value-added chemicals and selling these products to various industries domestically and internationally.
Revenue Mix
The company primarily operates under a single segment, "Chemical Products." Within this, its major product categories include:
Camphor: This is a flagship product and a significant revenue contributor, catering to religious, pharmaceutical, and aroma industries.
Synthetic Resins: These include various grades of terpene phenolic resins, rosin esters, and terpene resins used in diverse applications like adhesives, coatings, and printing inks.
By-products/Others: This segment includes products like Dipentene, Pinene, Isobornyl Acetate, and other aroma chemicals that are derivatives of turpentine oil processing.
The exact percentage contribution of each product category is not consistently disclosed but Camphor and Synthetic Resins are key drivers.
Industry
Mangalam Organics operates in the specialty chemicals sub-segment of the broader Indian chemicals industry. The industry is characterized by a mix of large diversified players and niche specialists. Mangalam Organics specializes in terpene chemistry and is a significant player in the camphor market in India. Its positioning is built on its integrated manufacturing facility for pine chemicals. The industry faces competition from both domestic manufacturers and imports, particularly from China, for certain products. The company aims to differentiate through product quality, customer relationships, and cost efficiencies in its specific niche.
MOAT
Process Know-how & Integration: Mangalam Organics possesses established expertise in terpene chemistry and integrated manufacturing facilities that allow it to process turpentine oil into various derivatives efficiently.
Scale in Niche: While not a giant in the overall chemical sector, it holds a significant market share in the Indian camphor market and specific terpene derivatives, which can offer some economies of scale within its niche.
Established Relationships: Long-standing relationships with customers across diverse industries (pharmaceuticals, F&F, adhesives) provide a degree of stability.
Branding (for Camphor): In the retail camphor segment, its "Mangalam" brand has established recognition among consumers, particularly for religious use.
Growth Drivers
Increasing Demand for Specialty Chemicals: Growing end-user industries like pharmaceuticals, personal care, adhesives, and F&F drive demand for its specialized products.
Shift from Unorganized to Organized Sector: The company benefits from the formalization of the market, especially for products like camphor, where it can capture market share from smaller, unorganized players.
Product Diversification & Value Addition: Expanding its portfolio of higher-value terpene derivatives and exploring new applications for its existing products can drive growth.
Export Opportunities: Tapping into global markets for its specialty chemicals, leveraging quality and cost competitiveness.
Infrastructure & Housing Boom: Demand for adhesives, paints, and coatings (which use its resins) could increase with infrastructure development.
Risks
Raw Material Price Volatility: Turpentine oil is a key raw material, and its price fluctuations, often linked to global crude oil prices or agricultural output, can impact margins significantly.
Intense Competition: The chemicals industry is competitive, with pressure from both domestic and international players (especially from China) leading to potential pricing pressure.
Environmental & Regulatory Risks: Strict environmental regulations, especially for chemical manufacturing, can lead to increased compliance costs or operational restrictions.
Economic Downturn: A slowdown in end-user industries (e.g., construction, manufacturing) can reduce demand for its products.
Forex Fluctuations: Exposure to international trade implies susceptibility to adverse foreign exchange rate movements.
Management & Ownership
Mangalam Organics Ltd. is a promoter-driven company. The Shah family are the promoters. Mr. Chaitanya Shah is the Managing Director and CEO, and Mr. Akshay Shah is a Joint Managing Director. The management team has long-standing experience in the chemical industry and has guided the company's growth and diversification within the terpene chemistry space. Promoter holding is significant, indicating strong alignment with shareholder interests. The company is professionally managed within a framework set by the promoter family.
Outlook
Mangalam Organics operates in a niche yet growing segment of the specialty chemicals industry. The company's focus on terpene chemistry and its established position in the Indian camphor market provide a stable base. Potential upsides include increasing demand from diverse end-user industries, successful expansion into higher-value derivatives, and benefits from the formalization of the chemical market. However, the company faces inherent risks associated with raw material price volatility, intense competition, and regulatory compliance. Its ability to manage these external factors while executing its strategy for product diversification and market expansion will be crucial for sustained performance. The significant promoter holding suggests stability in vision, but the company's growth trajectory will largely depend on its capacity to innovate and effectively navigate the cyclical nature of commodity prices and competitive pressures.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 105 | 118 | 138 | 124 | 150 | 147 | 158 | 164 | 154 | 179 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 4 | 21 | 0 | -20 | 0 |
| Total Income | 105 | 118 | 138 | 124 | 150 | 151 | 179 | 164 | 134 | 179 |
| Total Expenditure | 95 | 107 | 126 | 108 | 130 | 125 | 158 | 145 | 107 | 157 |
| Operating Profit | 10 | 11 | 12 | 16 | 20 | 26 | 21 | 19 | 27 | 22 |
| Interest | 4 | 4 | 4 | 6 | 8 | 6 | 7 | 8 | 7 | 7 |
| Depreciation | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 10 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 2 | 3 | 5 | 7 | 15 | 4 | 5 | 9 | 9 |
| Provision for Tax | -1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 |
| Profit After Tax | 2 | 2 | 2 | 4 | 5 | 12 | 3 | 4 | 6 | 7 |
| Adjustments | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 2 | 2 | 2 | 4 | 5 | 12 | 3 | 4 | 6 | 7 |
| Adjusted Earnings Per Share | 2.9 | 2 | 2.5 | 4.2 | 6 | 14.3 | 3.7 | 5.1 | 7 | 8.5 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 375 | 338 | 491 | 493 | 494 | 530 | 623 | 655 |
| Other Income | 1 | 1 | 1 | 0 | 1 | 0 | 5 | 1 |
| Total Income | 376 | 339 | 492 | 493 | 494 | 530 | 627 | 656 |
| Total Expenditure | 288 | 210 | 400 | 495 | 455 | 471 | 535 | 567 |
| Operating Profit | 87 | 129 | 92 | -2 | 39 | 59 | 93 | 89 |
| Interest | 5 | 1 | 4 | 14 | 16 | 21 | 28 | 29 |
| Depreciation | 9 | 14 | 15 | 18 | 20 | 21 | 28 | 28 |
| Exceptional Income / Expenses | -10 | 0 | 0 | 0 | 0 | 0 | -4 | -4 |
| Profit Before Tax | 63 | 114 | 73 | -34 | 4 | 17 | 33 | 27 |
| Provision for Tax | 15 | 30 | 19 | -7 | -0 | 4 | 8 | 6 |
| Profit After Tax | 48 | 85 | 54 | -27 | 4 | 13 | 26 | 20 |
| Adjustments | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 48 | 85 | 54 | -27 | 4 | 13 | 25 | 20 |
| Adjusted Earnings Per Share | 55.5 | 98.8 | 62.8 | -31.8 | 5.1 | 14.6 | 29.6 | 24.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 18% | 8% | 13% | 0% |
| Operating Profit CAGR | 58% | 0% | -6% | 0% |
| PAT CAGR | 100% | 0% | -21% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -8% | 9% | -9% | 25% |
| ROE Average | 8% | 5% | 5% | 13% |
| ROCE Average | 10% | 7% | 7% | 18% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 168 | 252 | 304 | 276 | 281 | 293 | 319 |
| Minority's Interest | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Borrowings | 9 | 0 | 52 | 41 | 21 | 35 | 55 |
| Other Non-Current Liabilities | 6 | 6 | 8 | -0 | 1 | 4 | 13 |
| Total Current Liabilities | 33 | 54 | 196 | 186 | 181 | 292 | 353 |
| Total Liabilities | 215 | 311 | 560 | 503 | 483 | 624 | 740 |
| Fixed Assets | 102 | 121 | 198 | 227 | 244 | 269 | 328 |
| Other Non-Current Assets | 6 | 0 | 18 | 12 | 14 | 37 | 11 |
| Total Current Assets | 107 | 190 | 344 | 264 | 225 | 317 | 401 |
| Total Assets | 215 | 311 | 560 | 503 | 483 | 624 | 740 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 1 | 1 | 1 | 1 | 2 | 0 |
| Cash Flow from Operating Activities | 93 | 26 | -84 | 77 | 73 | -8 | 1 |
| Cash Flow from Investing Activities | -59 | -28 | -100 | -41 | -40 | -67 | -60 |
| Cash Flow from Financing Activities | -36 | 2 | 183 | -36 | -33 | 74 | 60 |
| Net Cash Inflow / Outflow | -2 | 0 | -1 | 1 | 1 | -1 | 1 |
| Closing Cash & Cash Equivalent | 1 | 1 | 1 | 1 | 2 | 0 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 55.53 | 98.82 | 62.75 | -31.79 | 5.06 | 14.6 | 29.64 |
| CEPS(Rs) | 66.45 | 114.79 | 80.29 | -11.3 | 28.17 | 39.01 | 62.28 |
| DPS(Rs) | 1 | 1.5 | 1.5 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 196.04 | 293.86 | 355.04 | 321.9 | 327.7 | 342.3 | 371.94 |
| Core EBITDA Margin(%) | 23.05 | 37.78 | 18.54 | -0.56 | 7.83 | 11.05 | 14.11 |
| EBIT Margin(%) | 18.19 | 34.09 | 15.78 | -4.06 | 3.97 | 7.19 | 9.88 |
| Pre Tax Margin(%) | 16.8 | 33.79 | 14.92 | -6.85 | 0.81 | 3.14 | 5.35 |
| PAT Margin (%) | 12.8 | 25.06 | 10.95 | -5.53 | 0.87 | 2.38 | 4.14 |
| Cash Profit Margin (%) | 15.2 | 29.07 | 14.01 | -1.97 | 4.89 | 6.3 | 8.57 |
| ROA(%) | 22.31 | 32.22 | 12.34 | -5.12 | 0.87 | 2.28 | 3.78 |
| ROE(%) | 28.55 | 40.41 | 19.34 | -9.39 | 1.54 | 4.39 | 8.42 |
| ROCE(%) | 36.22 | 49.69 | 19.55 | -4.07 | 4.26 | 7.51 | 9.95 |
| Receivable days | 30.52 | 35.48 | 29.21 | 33.93 | 38.28 | 43.18 | 37.55 |
| Inventory Days | 63.07 | 92.2 | 130.18 | 160.55 | 120.23 | 120.13 | 150.48 |
| Payable days | 19.89 | 52.54 | 37.3 | 34.86 | 34.2 | 47.4 | 51.86 |
| PER(x) | 3.2 | 5.24 | 14.34 | 0 | 53.85 | 24.37 | 12.12 |
| Price/Book(x) | 0.91 | 1.76 | 2.53 | 1.03 | 0.83 | 1.04 | 0.97 |
| Dividend Yield(%) | 0.56 | 0.29 | 0.17 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.46 | 1.28 | 2 | 0.96 | 0.82 | 1.08 | 1.06 |
| EV/Core EBITDA(x) | 1.97 | 3.36 | 10.61 | -195.12 | 10.25 | 9.71 | 7.14 |
| Net Sales Growth(%) | 0 | -9.69 | 45.06 | 0.38 | 0.2 | 7.39 | 17.46 |
| EBIT Growth(%) | 0 | 69.23 | -32.87 | -125.8 | 198.17 | 94.31 | 61.4 |
| PAT Growth(%) | 0 | 76.86 | -36.61 | -150.66 | 115.74 | 193.91 | 104.46 |
| EPS Growth(%) | 0 | 77.95 | -36.5 | -150.66 | 115.93 | 188.33 | 103 |
| Debt/Equity(x) | 0.12 | 0.1 | 0.7 | 0.69 | 0.62 | 0.91 | 1.12 |
| Current Ratio(x) | 3.29 | 3.55 | 1.76 | 1.42 | 1.24 | 1.09 | 1.14 |
| Quick Ratio(x) | 1.3 | 1.57 | 0.51 | 0.4 | 0.49 | 0.36 | 0.28 |
| Interest Cover(x) | 13.05 | 115.1 | 18.44 | -1.45 | 1.26 | 1.77 | 2.18 |
| Total Debt/Mcap(x) | 0.13 | 0.05 | 0.27 | 0.67 | 0.74 | 0.88 | 1.16 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.91 | 54.91 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 |
| FII | 0.02 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 1.42 | 1.42 | 1.42 | 2.78 | 3.63 | 3.63 | 3.63 | 2.21 |
| Public | 45.07 | 45.09 | 39.81 | 39.93 | 39.93 | 38.57 | 37.72 | 37.72 | 37.72 | 39.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.47 | 0.47 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 |
| Public | 0.39 | 0.39 | 0.34 | 0.34 | 0.34 | 0.33 | 0.32 | 0.32 | 0.32 | 0.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +18% | +8% | +13% | — |
| Operating Profit CAGR | +58% | — | -6% | — |
| PAT CAGR | +100% | — | -21% | — |
| Share Price CAGR | -8% | +9% | -9% | +25% |
| ROE Average | +8% | +5% | +5% | +13% |
| ROCE Average | +10% | +7% | +7% | +18% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.91 | 54.91 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 | 58.65 |
| FII | 0.02 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 1.42 | 1.42 | 1.42 | 2.78 | 3.63 | 3.63 | 3.63 | 2.21 |
| Public | 45.07 | 45.09 | 39.81 | 39.93 | 39.93 | 38.57 | 37.72 | 37.72 | 37.72 | 39.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.47 | 0.47 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 |
| Public | 0.39 | 0.39 | 0.34 | 0.34 | 0.34 | 0.33 | 0.32 | 0.32 | 0.32 | 0.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.